Glycopyrrolate: all 130 studies that test it

Page 1 of 2. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.

• A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and HyperinflationRecruitingNCT07073950Phase 4
• A RCT to Compare the Effectiveness of Nebulized Anticholinergics for Cough Suppression During Flexible BronchoscopyNot yet recruitingNCT06376942Phase 2/3
• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseRecruitingNCT06283966Phase 3
• Antiperistaltic Effect and Safety of Glycopyrronium for Colonoscopic PolypectomyEnrolling by invitationNCT06041984Phase 1/2
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With AsthmaRecruitingNCT05222529Phase 2
• Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural PunctureRecruitingNCT05116930Phase 2
• A Phase IIb Study of Glycopyrrolate Inhalation Solution Over 1 Week in Subjects With COPDCompletedNCT06545500Phase 2Results posted
• Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular BlockCompletedNCT05545280Phase 4Results posted
• Functional Respiratory Imaging Study (DARWiIN)CompletedNCT04876677Phase 3Results posted
• Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)CompletedNCT04609904Phase 3Results posted
• Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)CompletedNCT04609878Phase 3Results posted
• Comparison of Time to Extubation Using Sugammadex or NeostigmineCompletedNCT04606901Phase 4Results posted
• Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting SurgeryCompletedNCT03939923Phase 4Results posted
• A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPDCompletedNCT03836677Phase 3Results posted
• Intraoperative Video Laryngoscopy as Adjunct for Nerve MonitoringCompletedNCT03742141Not applicableResults posted
• Patient-controlled Sedation With Propofol Versus Combined Sedation During BronchoscopyCompletedNCT03357393Not applicableResults posted
• Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler®CompletedNCT03262012Phase 3Results posted
• Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT03162055Phase 3Results posted
• Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in AsthmaCompletedNCT03137784Phase 2/3Results posted
• Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle RelaxantCompletedNCT03116997Phase 3Results posted
• Use of Sugammadex for Reversal of Paralysis in MicrolaryngoscopyCompletedNCT03111121Phase 4Results posted
• A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT03084796Phase 2Results posted
• A Study to Assess the Effects of PT001 and PT005 MDI on Specific Image Based Parameters in Subjects With Moderate to Severe COPDCompletedNCT02937584Phase 3Results posted
• Minimizing Nausea and Vomiting During Spinals for CSTerminatedNCT02872935Phase 4Results posted
• RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials CooperativeCompletedNCT02867761Phase 3Results posted
• Study to Evaluate the Treatment Effect of PT003 on Cardiovascular Hemodynamics in Subjects With Moderate to Severe COPDTerminatedNCT02685293Phase 3Results posted
• Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT02536508Phase 3Results posted
• Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT02512302Phase 1Results posted
• A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)CompletedNCT02497001Phase 3Results posted
• Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)CompletedNCT02465567Phase 3Results posted
• A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPDCompletedNCT02371629Phase 4Results posted
• 24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003 and Placebo MDICompletedNCT02347085Phase 3Results posted
• 24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva® Respimat® as an Active Control, and PlaceboCompletedNCT02347072Phase 3Results posted
• Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPDCompletedNCT02343458Phase 3Results posted
• Efficacy of LAMA Added to ICS in Treatment of Asthma (ELITRA)CompletedNCT02296411Phase 2Results posted
• A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02236611Phase 4Results posted
• Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)CompletedNCT02202616Phase 4Results posted
• Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary HyperhidrosisCompletedNCT02129660Phase 2Results posted
• A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary HyperhidrosisCompletedNCT02016885Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD RegimenCompletedNCT01985334Phase 4Results posted
• Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)CompletedNCT01970878Phase 3Results posted
• Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPDCompletedNCT01959516Phase 4Results posted
• Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01922271Phase 4Results posted
• Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPDCompletedNCT01917331Phase 3Results posted
• Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)CompletedNCT01854658Phase 3Results posted
• NVA237 BID Versus Placebo Twelve-week Efficacy StudyCompletedNCT01715298Phase 3Results posted
• NVA237 Versus Placebo 12-week Efficacy StudyCompletedNCT01709864Phase 3Results posted
• Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide.CompletedNCT01699685Phase 3Results posted
• Long Term Safety Study of NVA237 vs QAB149 in COPD PatientsCompletedNCT01697696Phase 3Results posted
• Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01613326Phase 3Results posted
• Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01604278Phase 3Results posted
• Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01587079Phase 2Results posted
• PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPDCompletedNCT01566773Phase 2Results posted
• Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01566604Phase 3Results posted
• Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01513460Phase 3Results posted
• PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01350128Phase 2Results posted
• PT003 MDI Dose Confirmation StudyCompletedNCT01349816Phase 2Results posted
• PT003 MDI Cardiovascular Safety StudyCompletedNCT01349803Phase 2Results posted
• Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine SedationCompletedNCT01191398Not applicableResults posted
• Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01154127Phase 3Results posted
• Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01119950Phase 2Results posted
• Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese PatientsCompletedNCT01119937Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01085045Phase 2Results posted
• A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus PlaceboCompletedNCT01005901Phase 3Results posted
• 1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00929110Phase 3Results posted
• Study to Evaluate Single Inhaled Doses of PT001, PT003, PT005 and PT001 Plus PT005 in Healthy SubjectsCompletedNCT00893971Phase 1Results posted
• A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00856193Phase 2Results posted
• Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00570778Phase 2Results posted
• Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00558285Phase 2Results posted
• Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT00510510Phase 2Results posted
• Efficacy and Safety of Four Doses of Glycopyrronium Bromide (NVA237) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), in Comparison to an Active Comparator TiotropiumCompletedNCT00501852Phase 2Results posted
• Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPDSuspendedNCT07541378Not applicable
• A Phase II Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Single Inhaled Doses of Ensifentrine-glycopyrrolate Fixed Dose Combination, Ensifentrine, and Glycopyrrolate in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT07132983Phase 2
• Clinical Study of Ensifentrine-Glycopyrrolate (MK-5884A/RPL554) Fixed-dose Combination Dose Ranging in Participants With COPD (MK-5884A-029/RPL554-CO-212)CompletedNCT07016412Phase 2
• Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover StudyCompletedNCT06905483Phase 4
• Effects of Glycopyrrolate on Heart Rate and Heart Rate Variability in Patients With Different Basic Heart RateCompletedNCT06237478Not applicable
• Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly PatientsCompletedNCT06228092Phase 4
• Effect of Glycopyrrolate on Nausea and Vomiting After ERCP OperationCompletedNCT06045364Phase 1/2
• Glycopyrrolate Prophylaxis for Prevention of Bradyarrhythmia During Laparoscopic CholecystectomyCompletedNCT05997004Not applicable
• The Impact of Sugammadex on Ileus After Abdominal Wall ReconstructionCompletedNCT05985343Phase 4
• Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary HyperhidrosisCompletedNCT05863104Phase 2
• A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV)CompletedNCT05830071Phase 1
• Effect of Perioperative Use of Glycopyrrolate on Lung Function in Patients Under General AnesthesiaCompletedNCT05693246Not applicable
• Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference ProductCompletedNCT05288075Phase 1
• Comparison of Postoperative Anti-nausea and Vomiting Effect Between Glycopyrronium and OndansetronStatus unknownNCT05265507Phase 4
• Combined Dexmedetomidine and Glycopyrrolate TherapyWithdrawnNCT05013320Not applicable
• An Open Label Study for Palmar HyperhydrosisCompletedNCT04906655Phase 2
• Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCICompletedNCT04671030Phase 1
• The Off Label Use of Glycopyrrolate in the Adults Intensive Care Unit.Status unknownNCT04554589Phase 1
• Effect of Glycopyrrolate on Vasopressors Requirement for Non-elective Caesarean Section Under Spinal AnaesthesiaCompletedNCT04401345Phase 4
• A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPDCompletedNCT04320342Phase 3
• The Use of Sugammadex in the Critically IllStatus unknownNCT03791801Not applicable
• Atropine Versus Glycopyrrolate in Preventing Spinal Anesthesia Induced Hypotension in Lower Limb SurgeriesStatus unknownNCT03580889Phase 4
• Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn SurgeryCompletedNCT03513406Phase 3
• Utilizing Wearable Device to Observe the Clinical Response of COPD Patients Treated With Combined Bronchodilator and Home-based Pulmonary Rehabilitation ProgramStatus unknownNCT03364829Phase 4
• Effect of Atropine or Glycopyrrolate on the Prevention of Bradycardia During Sedation Using Dexmedetomidine in Adult Patients Undergoing Lower Extremity Surgery Under Spinal AnesthesiaTerminatedNCT03322150Not applicable
• Effect of Atropine or Glycopyrrolate on the Prevention of Bradycardia During Sedation Using Dexmedetomidine in Geriatric Patients Undergoing Total Knee Replacement Under Spinal AnesthesiaCompletedNCT03322098Not applicable
• Functional Respiratory Imaging Study (FRI)CompletedNCT03268226Phase 3
• Benefits of Glycopyrrolate on Intubation With Rigid-videostylet (OptiScope®)CompletedNCT03050242Not applicable
• Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001CompletedNCT03004495Phase 1

← Glycopyrrolate overview